M Kleine-Brueggeney1, R Greif2, P Schoettker3, G L Savoldelli4, S Nabecker2, L G Theiler2. 1. Department of Anaesthesiology and Pain Therapy, Inselspital, University Hospital Bern and University of Bern, Switzerland Department of Anaesthesia and Intensive Care, Barts Heart Centre, London, UK maren.kleine-brueggeney@insel.ch. 2. Department of Anaesthesiology and Pain Therapy, Inselspital, University Hospital Bern and University of Bern, Switzerland. 3. Department of Anaesthesiology, University Hospital Centre and University of Lausanne, Lausanne, Switzerland. 4. Division of Anaesthesiology, University Hospitals of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Abstract
BACKGROUND: Videolaryngoscopes are aggressively marketed, but independent evaluation in difficult airways is scarce. This multicentre, prospective randomized controlled trial evaluates six videolaryngoscopes in patients with a simulated difficult airway. METHODS: With ethics committee approval and written informed consent, 12 senior anaesthetists intubated the trachea of 720 patients. A cervical collar limited mouth opening and neck movement, making intubation difficult. We evaluated three unchannelled (C-MAC™ D-blade, GlideScope™, and McGrath™) and three channelled videolaryngoscopes (Airtraq™, A.P. Advance™ difficult airway blade, and KingVision™). The primary outcome was first-attempt intubation success rate. Secondary outcomes included overall success rate, laryngeal view, intubation times, and side-effects. The primary hypothesis for every videolaryngoscope was that the 95% confidence interval of first-attempt success rate is ≥90%. RESULTS:Mouth opening was decreased from 46 (sd 7) to 23 (3) mm with the cervical collar. First-attempt success rates were 98% (McGrath™), 95% (C-MAC™ D-blade), 87% (KingVision™), 85% (GlideScope™ and Airtraq™), and 37% (A.P. Advance™, P<0.01). The 95% confidence interval of first-attempt success rate was >90% only for the McGrath™. Overall success, laryngeal view, and intubation times differed significantly between videolaryngoscopes (all P<0.01). Side-effects were minor. CONCLUSIONS: This trial revealed differences in the performance of six videolaryngoscopes in 720 patients with restricted neck movement and limited mouth opening. In this setting, first-attempt success rates were 85-98%, except for the A.P. Advance™ difficult airway blade. Highest success and lowest tissue trauma rates were achieved by the McGrath™ and C-MAC™ D-blade, highlighting the importance of the videolaryngoscope blade design. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: identifier NCT01692535.
RCT Entities:
BACKGROUND: Videolaryngoscopes are aggressively marketed, but independent evaluation in difficult airways is scarce. This multicentre, prospective randomized controlled trial evaluates six videolaryngoscopes in patients with a simulated difficult airway. METHODS: With ethics committee approval and written informed consent, 12 senior anaesthetists intubated the trachea of 720 patients. A cervical collar limited mouth opening and neck movement, making intubation difficult. We evaluated three unchannelled (C-MAC™ D-blade, GlideScope™, and McGrath™) and three channelled videolaryngoscopes (Airtraq™, A.P. Advance™ difficult airway blade, and KingVision™). The primary outcome was first-attempt intubation success rate. Secondary outcomes included overall success rate, laryngeal view, intubation times, and side-effects. The primary hypothesis for every videolaryngoscope was that the 95% confidence interval of first-attempt success rate is ≥90%. RESULTS:Mouth opening was decreased from 46 (sd 7) to 23 (3) mm with the cervical collar. First-attempt success rates were 98% (McGrath™), 95% (C-MAC™ D-blade), 87% (KingVision™), 85% (GlideScope™ and Airtraq™), and 37% (A.P. Advance™, P<0.01). The 95% confidence interval of first-attempt success rate was >90% only for the McGrath™. Overall success, laryngeal view, and intubation times differed significantly between videolaryngoscopes (all P<0.01). Side-effects were minor. CONCLUSIONS: This trial revealed differences in the performance of six videolaryngoscopes in 720 patients with restricted neck movement and limited mouth opening. In this setting, first-attempt success rates were 85-98%, except for the A.P. Advance™ difficult airway blade. Highest success and lowest tissue trauma rates were achieved by the McGrath™ and C-MAC™ D-blade, highlighting the importance of the videolaryngoscope blade design. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: identifier NCT01692535.
Authors: Jiyoung Lee; Jong Yeop Kim; Se Yoon Kang; Hyun Jeong Kwak; Dongchul Lee; Sook Young Lee Journal: Medicine (Baltimore) Date: 2017-02 Impact factor: 1.889
Authors: Lukas E Wolf; José A Aguirre; Christian Vogt; Christian Keller; Alain Borgeat; Heinz R Bruppacher Journal: BMC Anesthesiol Date: 2017-01-10 Impact factor: 2.217
Authors: Hye Jin Kim; Hye Rim Kim; So Yeon Kim; Ha Yan Kim; Wyun Kon Park; Min Ho Lee; Hyun Joo Kim Journal: J Clin Monit Comput Date: 2021-07-12 Impact factor: 1.977